OvCaRe Publications

To see all OvCaRe Publications since 1990, click here.

1. Carey, M.S., Agarwal, R., Gilks, B., Swenerton, K., Kalloger, S., Santos, J., Ju, Z., Lu, Y., Zhang, F., Coombes, K.R., Miller, D., Huntsman, D., Mills, G.B. and Hennessy, B.T. (2010) Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy Clin Cancer Res, 16: p. 2852-60. [PMID: 20460476]

2. Chen, J., An, B.S., So, W.K., Cheng, L., Hammond, G.L. and Leung, P.C. (2010) Gonadotropin-releasing hormone-I-mediated activation of progesterone receptor contributes to gonadotropin alpha-subunit expression in mouse gonadotrophs Endocrinology, 151: p. 1204-11. [PMID: 20051488]

3. Cheung, L.W., Leung, P.C. and Wong, A.S. (2010) Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer Oncogene, 29: p. 2427-40. [PMID: 20118984]

4. Clarke, B.A. and Gilks, C.B. (2010) Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type J Clin Pathol, 63: p. 410-5. [PMID: 20418232]

5. Guo, J., Schally, A.V., Zarandi, M., Varga, J. and Leung, P.C. (2010) Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway Reprod Biol Endocrinol, 8: p. 54. [PMID: 20509930]

6. Kim, K.Y., Kim, S.U., Leung, P.C., Jeung, E.B. and Choi, K.C. (2010) Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth Cancer Sci. [PMID: 20132217]

7. Kobel, M., Kalloger, S.E., Baker, P.M., Ewanowich, C.A., Arseneau, J., Zherebitskiy, V., Abdulkarim, S., Leung, S., Duggan, M.A., Fontaine, D., Parker, R., Huntsman, D.G. and Gilks, C.B. (2010) Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study Am J Surg Pathol. [PMID: 20505499]

8. Kobel, M., Kalloger, S.E., Huntsman, D.G., Santos, J.L., Swenerton, K.D., Seidman, J.D. and Gilks, C.B. (2010) Differences in tumor type in low-stage versus high-stage ovarian carcinomas Int J Gynecol Pathol, 29: p. 203-11. [PMID: 20407318]

9. Lau, M.T., Wong, A.S. and Leung, P.C. (2010) Gonadotropins Induce Tumor Cell Migration and Invasion by Increasing Cyclooxygenases Expression and Prostaglandin E2 Production in Human Ovarian Cancer Cells Endocrinology. [PMID: 20392831]

10. Wang, T.T., Wu, Y.T., Dong, M.Y., Sheng, J.Z., Leung, P.C. and Huang, H.F. (2010) G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve Fertil Steril. [PMID: 20451184]

11. Webb, J.R., Wick, D.A., Nielsen, J.S., Tran, E., Milne, K., McMurtrie, E. and Nelson, B.H. (2010) Profound elevation of CD8(+) T cells expressing the intraepithelial lymphocyte marker CD103 (alpha(E)/beta(7) Integrin) in high-grade serous ovarian cancer Gynecol Oncol. [PMID: 20541243]

12. Zhang, Y., Huang, Q., Cheng, J.C., Nishi, Y., Yanase, T., Huang, H.F. and Leung, P.C. (2010) Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells Reprod Biol Endocrinol, 8: p. 61. [PMID: 20540809]

13. Gainford, M.C., Tinker, A., Carter, J., Petru, E., Nicklin, J., Quinn, M., Hammond, I., Elit, L., Lenhard, M. and Friedlander, M. (2010). Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an australia new zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study Int J Gynecol Cancer, 20: p. 75-81. [PMID: 20130506]

14. Gilks, C.B. (2010). Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma J Oncol, 2010: p. 740968. [PMID: 20069115]

15. Goya, R., Sun, M.G., Morin, R.D., Leung, G., Ha, G., Wiegand, K.C., Senz, J., Crisan, A., Marra, M.A., Hirst, M., Huntsman, D., Murphy, K.P., Aparicio, S. and Shah, S.P. (2010). SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors Bioinformatics, 26: p. 730-6. [PMID: 20130035]

16. Kobel, M., Kalloger, S.E., Santos, J.L., Huntsman, D.G., Gilks, C.B. and Swenerton, K.D. (2010). Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications Gynecol Oncol, 116: p. 50-6. [PMID: 19822358]

17. Mackay, H.J., Tinker, A., Winquist, E., Thomas, G., Swenerton, K., Oza, A., Sederias, J., Ivy, P. and Eisenhauer, E.A. (2010). A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184 Gynecol Oncol, 116: p. 163-7. [PMID: 19740535]

18. Madore, J., Ren, F., Filali-Mouhim, A., Sanchez, L., Kobel, M., Tonin, P.N., Huntsman, D., Provencher, D.M. and Mes-Masson, A.M. (2010). Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma J Pathol, 220: p. 392-400. [PMID: 19967725]

19. Maines-Bandiera, S., Woo, M.M., Borugian, M., Molday, L.L., Hii, T., Gilks, B., Leung, P.C., Molday, R.S. and Auersperg, N. (2010). Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer Int J Gynecol Cancer, 20: p. 16-22. [PMID: 20130498]

20. Tabrizi, A.D., Kalloger, S.E., Kobel, M., Cipollone, J., Roskelley, C.D., Mehl, E. and Gilks, C.B. (2010). Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol, 29: p. 99-107. [PMID: 20173494]

21. Zheng, J., Mercado-Uribe, I., Rosen, D.G., Chang, B., Liu, P., Yang, G., Malpica, A., Noara, H., Auersperg, N., Mills, G.B., Bast, R.C. and Liu, J. (2010). Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment Cell Cycle, 9: p. 140-6. [PMID: 20016289]

22. An, B.S., Poon, S.L., So, W.K., Hammond, G.L. and Leung, P.C. (2009). Rapid effect of GNRH1 on follicle-stimulating hormone beta gene expression in LbetaT2 mouse pituitary cells requires the progesterone receptor Biol Reprod, 81: p. 243-9. [PMID: 19357364]

23. Chen, J., An, B.S., Cheng, L., Hammond, G.L. and Leung, P.C. (2009). Gonadotropin-releasing hormone-mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse gonadotrophs Endocrinology, 150: p. 4583-93. [PMID: 19574399]

24. Choi, J.H., Chen, C.L., Poon, S.L., Wang, H.S. and Leung, P.C. (2009). Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway Endocr Relat Cancer, 16: p. 179-88. [PMID: 19022848]

25. Clarke, B., Tinker, A.V., Lee, C.H., Subramanian, S., van de Rijn, M., Turbin, D., Kalloger, S., Han, G., Ceballos, K., Cadungog, M.G., Huntsman, D.G., Coukos, G. and Gilks, C.B. (2009). Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss Mod Pathol, 22: p. 393-402. [PMID: 19060844]

26. Espinosa, I., Beck, A.H., Lee, C.H., Zhu, S., Montgomery, K.D., Marinelli, R.J., Ganjoo, K.N., Nielsen, T.O., Gilks, C.B., West, R.B. and van de Rijn, M. (2009). Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma Am J Pathol, 174: p. 2347-56. [PMID: 19443701]

27. Etemadmoghadam, D., deFazio, A., Beroukhim, R., Mermel, C., George, J., Getz, G., Tothill, R., Okamoto, A., Raeder, M.B., Harnett, P., Lade, S., Akslen, L.A., Tinker, A.V., Locandro, B., Alsop, K., Chiew, Y.E., Traficante, N., Fereday, S., Johnson, D., Fox, S., Sellers, W., Urashima, M., Salvesen, H.B., Meyerson, M. and Bowtell, D. (2009). Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas Clin Cancer Res, 15: p. 1417-27. [PMID: 19193619]

28. Gilks, C.B. and Prat, J. (2009). Ovarian carcinoma pathology and genetics: recent advances Hum Pathol, 40: p. 1213-23. [PMID: 19552940]

29. Huang, Q., Cheung, A.P., Zhang, Y., Huang, H.F., Auersperg, N. and Leung, P.C. (2009). Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation Am J Physiol Endocrinol Metab, 296: p. E1344-53. [PMID: 19366876]

30. Klausen, C., Leung, P.C. and Auersperg, N. (2009). Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin Mol Cancer Res, 7: p. 1425-37. [PMID: 19723874]

31. Kobel, M., Gilks, C.B. and Huntsman, D.G. (2009). Adult-type granulosa cell tumors and FOXL2 mutation Cancer Res, 69: p. 9160-2. [PMID: 19996294]

32. Kobel, M., Gilks, C.B. and Huntsman, D.G. (2009). Dicer and Drosha in ovarian cancer N Engl J Med, 360: p. 1150-1; author reply 1151. [PMID: 19279349]

33. Kobel, M., Kalloger, S.E., Carrick, J., Huntsman, D., Asad, H., Oliva, E., Ewanowich, C.A., Soslow, R.A. and Gilks, C.B. (2009). A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary Am J Surg Pathol, 33: p. 14-21. [PMID: 18830127]

34. Kobel, M., Xu, H., Bourne, P.A., Spaulding, B.O., Shih Ie, M., Mao, T.L., Soslow, R.A., Ewanowich, C.A., Kalloger, S.E., Mehl, E., Lee, C.H., Huntsman, D. and Gilks, C.B. (2009). IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype Mod Pathol, 22: p. 469-75. [PMID: 19136932]

35. Lee, C.H., Subramanian, S., Beck, A.H., Espinosa, I., Senz, J., Zhu, S.X., Huntsman, D., van de Rijn, M. and Gilks, C.B. (2009). MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary PLoS ONE, 4: p. e7314. [PMID: 19798417]

36. Lin, Q., Poon, S.L., Chen, J., Cheng, L., HoYuen, B. and Leung, P.C. (2009). Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells Reprod Biol Endocrinol, 7: p. 115. [PMID: 19849856]

37. Liu, J., Maccalman, C.D., Wang, Y.L. and Leung, P.C. (2009). Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways Mol Endocrinol, 23: p. 1014-21. [PMID: 19372239]

38. Liu, P., Khurana, A., Rattan, R., He, X., Kalloger, S., Dowdy, S., Gilks, B. and Shridhar, V. (2009). Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer Cancer Res, 69: p. 4843-50. [PMID: 19487294]

39. McAlpine, J.N., Wiegand, K.C., Vang, R., Ronnett, B.M., Adamiak, A., Kobel, M., Kalloger, S.E., Swenerton, K.D., Huntsman, D.G., Gilks, C.B. and Miller, D.M. (2009). HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy BMC Cancer, 9: p. 433. [PMID: 20003286]

40. Milne, K., Kobel, M., Kalloger, S.E., Barnes, R.O., Gao, D., Gilks, C.B., Watson, P.H. and Nelson, B.H. (2009). Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors PLoS ONE, 4: p. e6412. [PMID: 19641607]

41. Nelson, B.H. (2009). IDO and outcomes in ovarian cancer Gynecol Oncol, 115: p. 179-80. [PMID: 19822256]

42. Ota, T., Klausen, C., Salamanca, M.C., Woo, H.L., Leung, P.C. and Auersperg, N. (2009). Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells Differentiation, 77: p. 162-71. [PMID: 19281776]

43. Park, D.W., Choi, K.C., MacCalman, C.D. and Leung, P.C. (2009). Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase Reprod Biol Endocrinol, 7: p. 81. [PMID: 19656390]

44. Park, S.H., Kim, K.Y., An, B.S., Choi, J.H., Jeung, E.B., Leung, P.C. and Choi, K.C. (2009). Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38 J Reprod Dev, 55: p. 23-9. [PMID: 18854640]

45. Poon, S.L., Hammond, G.T. and Leung, P.C. (2009). Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion Mol Endocrinol, 23: p. 1646-56. [PMID: 19608641]

46. Salvador, S., Gilks, B., Kobel, M., Huntsman, D., Rosen, B. and Miller, D. (2009). The fallopian tube: primary site of most pelvic high-grade serous carcinomas Int J Gynecol Cancer, 19: p. 58-64. [PMID: 19258943]

47. Schrader, K.A., Gorbatcheva, B., Senz, J., Heravi-Moussavi, A., Melnyk, N., Salamanca, C., Maines-Bandiera, S., Cooke, S.L., Leung, P., Brenton, J.D., Gilks, C.B., Monahan, J. and Huntsman, D.G. (2009). The specificity of the FOXL2 c.402C>G Somatic mutation: a survey of solid tumors PLoS ONE, 4: p. e7988. [PMID: 19956657]

48. Shah, S.P., Kobel, M., Senz, J., Morin, R.D., Clarke, B.A., Wiegand, K.C., Leung, G., Zayed, A., Mehl, E., Kalloger, S.E., Sun, M., Giuliany, R., Yorida, E., Jones, S., Varhol, R., Swenerton, K.D., Miller, D., Clement, P.B., Crane, C., Madore, J., Provencher, D., Leung, P., Defazio, A., Khattra, J., Turashvili, G., Zhao, Y., Zeng, T., Glover, J.N., Vanderhyden, B., Zhao, C., Parkinson, C.A., Jimenez-Linan, M., Bowtell, D.D., Mes-Masson, A.M., Brenton, J.D., Aparicio, S.A., Boyd, N., Hirst, M., Gilks, C.B., Marra, M. and Huntsman, D.G. (2009). Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary N Engl J Med, epub ahead of print. [PMID: 19516027]

49. Shi, F.T., Cheung, A.P., Huang, H.F. and Leung, P.C. (2009). Effects of endogenous growth differentiation factor 9 on activin A-induced inhibin B production in human granulosa-lutein cells J Clin Endocrinol Metab, 94: p. 5108-16. [PMID: 19846738]

50. Shi, F.T., Cheung, A.P. and Leung, P.C. (2009). Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells Endocrinology, 150: p. 3540-6. [PMID: 19423755]

51. Tang, L., Zhang, Y., Pan, H., Luo, Q., Zhu, X.M., Dong, M.Y., Leung, P.C., Sheng, J.Z. and Huang, H.F. (2009). Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell Reprod Biol Endocrinol, 7: p. 144. [PMID: 19968870]

52. Wu, H.M., Cheng, J.C., Wang, H.S., Huang, H.Y., MacCalman, C.D. and Leung, P.C. (2009). Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha Cancer Res, 69: p. 4202-8. [PMID: 19366794]

53. Wu, H.M., Wang, H.S., Huang, H.Y., Soong, Y.K., MacCalman, C.D. and Leung, P.C. (2009). GnRH signaling in intrauterine tissues Reproduction, 137: p. 769-77. [PMID: 19208750]

54. Anglesio, M.S., Arnold, J.M., George, J., Tinker, A.V., Tothill, R., Waddell, N., Simms, L., Locandro, B., Fereday, S., Traficante, N., Russell, P., Sharma, R., Birrer, M.J., deFazio, A., Chenevix-Trench, G. and Bowtell, D.D. (2008). Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors Mol Cancer Res, 6: p. 1678-90. [PMID: 19010816]

55. Astanehe, A., Arenillas, D., Wasserman, W.W., Leung, P.C., Dunn, S.E., Davies, B.R., Mills, G.B. and Auersperg, N. (2008). Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer J Cell Sci, 121: p. 664-74. [PMID: 18270270]

56. Auersperg, N., Woo, M.M. and Gilks, C.B. (2008). The origin of ovarian carcinomas: a developmental view Gynecol Oncol, 110: p. 452-4. [PMID: 18603285]

57. Brown, L.A., Kalloger, S.E., Miller, M.A., Shih Ie, M., McKinney, S.E., Santos, J.L., Swenerton, K., Spellman, P.T., Gray, J., Gilks, C.B. and Huntsman, D.G. (2008). Amplification of 11q13 in ovarian carcinoma Genes Chromosomes Cancer, 47: p. 481-9. [PMID: 18314909]

58. Dimple, C., Nair, S.S., Rajhans, R., Pitcheswara, P.R., Liu, J., Balasenthil, S., Le, X.F., Burow, M.E., Auersperg, N., Tekmal, R.R., Broaddus, R.R. and Vadlamudi, R.K. (2008). Role of PELP1/MNAR signaling in ovarian tumorigenesis Cancer Res, 68: p. 4902-9. [PMID: 18559538]

59. Gilks, C.B., Ionescu, D.N., Kalloger, S.E., Kobel, M., Irving, J., Clarke, B., Santos, J., Le, N., Moravan, V. and Swenerton, K. (2008). Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma Hum Pathol, 39: p. 1239-51. [PMID: 18602670]

60. Han, G., Gilks, C.B., Leung, S., Ewanowich, C.A., Irving, J.A., Longacre, T.A. and Soslow, R.A. (2008). Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases Am J Surg Pathol, 32: p. 955-64. [PMID: 18460981]

61. Hennessy, B.T., Murph, M., Nanjundan, M., Carey, M., Auersperg, N., Almeida, J., Coombes, K.R., Liu, J., Lu, Y., Gray, J.W. and Mills, G.B. (2008). Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead Adv Exp Med Biol, 617: p. 23-40. [PMID: 18497028]

62. Hong, I.S., Cheung, A.P. and Leung, P.C. (2008). Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells J Clin Endocrinol Metab, 93: p. 3179-85. [PMID: 18477660]

63. Hoskins, P.J., Le, N., Ellard, S., Lee, U., Martin, L.A., Swenerton, K.D. and Tinker, A.V. (2008). Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience Gynecol Oncol, 108: p. 58-62. [PMID: 17935761]

64. Kobel, M., Huntsman, D. and Gilks, C.B. (2008). Critical molecular abnormalities in high-grade serous carcinoma of the ovary Expert Rev Mol Med, 10: p. e22. [PMID: 18671886]

65. Kobel, M., Kalloger, S.E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N.J., Ionescu, D.N., Rajput, A., Prentice, L.M., Miller, D., Santos, J., Swenerton, K., Gilks, C.B. and Huntsman, D. (2008). Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med, 5: p. e232. [PMID: 19053170]

66. McIntosh, M. anderson, G., Drescher, C., Hanash, S., Urban, N., Brown, P., Gambhir, S.S., Coukos, G., Laird, P.W., Nelson, B. and Palmer, C. (2008). Ovarian cancer early detection claims are biased Clin Cancer Res, 14: p. 7574; author reply 7577-9. [PMID: 18948385]

67. Milne, K., Barnes, R.O., Girardin, A., Mawer, M.A., Nesslinger, N.J., Ng, A., Nielsen, J.S., Sahota, R., Tran, E., Webb, J.R., Wong, M.Q., Wick, D.A., Wray, A., McMurtrie, E., Kobel, M., Kalloger, S.E., Gilks, C.B., Watson, P.H. and Nelson, B.H. (2008). Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer PLoS ONE, 3: p. e3409. [PMID: 18923710]

68. Natesampillai, S., Kerkvliet, J., Leung, P.C. and Veldhuis, J.D. (2008). Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells Am J Physiol Endocrinol Metab, 294: p. E385-91. [PMID: 18056793]

69. Nelson, B.H. (2008). The impact of T-cell immunity on ovarian cancer outcomes Immunol Rev, 222: p. 101-16. [PMID: 18363996]

70. Ota, T., Asahina, H., Park, S.H., Huang, Q., Minegishi, T., Auersperg, N. and Leung, P.C. (2008). HOX cofactors expression and regulation in the human ovary Reprod Biol Endocrinol, 6: p. 49. [PMID: 18973687]

71. Palmer, C., Duan, X., Hawley, S., Scholler, N., Thorpe, J.D., Sahota, R.A., Wong, M.Q., Wray, A., Bergan, L.A., Drescher, C.W., McIntosh, M.W., Brown, P.O., Nelson, B.H. and Urban, N. (2008). Systematic evaluation of candidate blood markers for detecting ovarian cancer PLoS ONE, 3: p. e2633. [PMID: 18612378]

72. Pinke, D.E., Kalloger, S.E., Francetic, T., Huntsman, D.G. and Lee, J.M. (2008). The prognostic significance of elongation factor eEF1A2 in ovarian cancer Gynecol Oncol, 108: p. 561-8. [PMID: 18164751]

73. Press, J.Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S.E., Blood, K.A., Smith, M., Spellman, P.T., Wang, Y., Miller, D.M., Horsman, D., Faham, M., Gilks, C.B., Gray, J. and Huntsman, D.G. (2008). Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities BMC Cancer, 8: p. 17. [PMID: 18208621]

74. Press, J.Z., Kenyon, J.A., Xue, H., Miller, M.A., De Luca, A., Miller, D.M., Huntsman, D.G., Gilks, C.B., McAlpine, J.N. and Wang, Y.Z. (2008). Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy Gynecol Oncol, 110: p. 256-64. [PMID: 18547621]

75. Ronnett, B.M., Yemelyanova, A.V., Vang, R., Gilks, C.B., Miller, D., Gravitt, P.E. and Kurman, R.J. (2008). Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms Am J Surg Pathol, 32: p. 1835-53. [PMID: 18813124]

76. Salvador, S., Rempel, A., Soslow, R.A., Gilks, B., Huntsman, D. and Miller, D. (2008). Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma Gynecol Oncol, 110: p. 408-17. [PMID: 18597838]

77. Singh, R., Graves, M.L., Roskelley, C.D., Giritharan, G. and Rajamahendran, R. (2008). Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts Domest Anim Endocrinol, 34: p. 319-26. [PMID: 18035513]

78. Sun, Y., Wong, N., Guan, Y., Salamanca, C.M., Cheng, J.C., Lee, J.M., Gray, J.W. and Auersperg, N. (2008). The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas Int J Cancer, 123: p. 1761-9. [PMID: 18661515]

79. Tothill, R.W., Tinker, A.V., George, J., Brown, R., Fox, S.B., Lade, S., Johnson, D.S., Trivett, M.K., Etemadmoghadam, D., Locandro, B., Traficante, N., Fereday, S., Hung, J.A., Chiew, Y.E., Haviv, I., Gertig, D., DeFazio, A. and Bowtell, D.D. (2008). Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res, 14: p. 5198-208. [PMID: 18698038]

80. Weichert, W., Denkert, C., Noske, A., Darb-Esfahani, S., Dietel, M., Kalloger, S.E., Huntsman, D.G. and Kobel, M. (2008). Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas Neoplasia, 10: p. 1021-7. [PMID: 18714364]

81. Woo, M.M., Salamanca, C.M., Miller, M., Symowicz, J., Leung, P.C., Oliveira, C., Ehlen, T.G., Gilks, C.B., Huntsman, D. and Auersperg, N. (2008). Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas Int J Gynecol Cancer, 18: p. 1234-47. [PMID: 18217967]

82. Woo, M.M., Salamanca, C.M., Symowicz, J., Stack, M.S., Miller, D.M., Leung, P.C., Gilks, C.B. and Auersperg, N. (2008). SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells Gynecol Oncol, 111: p. 125-31. [PMID: 18678400]

83. Wu, C., Cipollone, J., Maines-Bandiera, S., Tan, C., Karsan, A., Auersperg, N. and Roskelley, C.D. (2008). The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression Differentiation, 76: p. 193-205. [PMID: 17608733]

84. Chen, C.L., Cheung, L.W., Lau, M.T., Choi, J.H., Auersperg, N., Wang, H.S., Wong, A.S. and Leung, P.C. (2007). Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion Endocrine, 31: p. 311-20. [PMID: 17906381]

85. Graves, M.L., Zhou, L., MacDonald, G., Mueller, C.R. and Roskelley, C.D. (2007). Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells FEBS Lett, 581: p. 1825-33. [PMID: 17434164]

86. Guan, Y., Kuo, W.L., Stilwell, J.L., Takano, H., Lapuk, A.V., Fridlyand, J., Mao, J.H., Yu, M., Miller, M.A., Santos, J.L., Kalloger, S.E., Carlson, J.W., Ginzinger, D.G., Celniker, S.E., Mills, G.B., Huntsman, D.G. and Gray, J.W. (2007). Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer Clin Cancer Res, 13: p. 5745-55. [PMID: 17908964]

87. He, X., Pool, M., Darcy, K.M., Lim, S.B., Auersperg, N., Coon, J.S. and Beck, W.T. (2007). Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro Oncogene, 26: p. 4961-8. [PMID: 17310993]

88. Leung, P.C. and Choi, J.H. (2007). Endocrine signaling in ovarian surface epithelium and cancer Hum Reprod Update, 13: p. 143-62. [PMID: 17071638]

89. Li, P., Maines-Bandiera, S., Kuo, W.L., Guan, Y., Sun, Y., Hills, M., Huang, G., Collins, C.C., Leung, P.C., Gray, J.W. and Auersperg, N. (2007). Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression Int J Cancer, 120: p. 1863-73. [PMID: 17266044]

90. Ota, T., Gilks, C.B., Longacre, T., Leung, P.C. and Auersperg, N. (2007). HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features Reprod Sci, 14: p. 605-14. [PMID: 17959889]

91. Prentice, L.M., Klausen, C., Kalloger, S., Kobel, M., McKinney, S., Santos, J.L., Kenney, C., Mehl, E., Gilks, C.B., Leung, P., Swenerton, K., Huntsman, D.G. and Aparicio, S.A. (2007). Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma BMC Med, 5: p. 33. [PMID: 18005407]

92. Schumacher, J.J., Dings, R.P., Cosin, J., Subramanian, I.V., Auersperg, N. and Ramakrishnan, S. (2007). Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells Cancer Res, 67: p. 3683-90. [PMID: 17440080]

93. Thorpe, J.D., Duan, X., Forrest, R., Lowe, K., Brown, L., Segal, E., Nelson, B. anderson, G.L., McIntosh, M. and Urban, N. (2007). Effects of blood collection conditions on ovarian cancer serum markers PLoS ONE, 2: p. e1281. [PMID: 18060075]

94. Tinker, A.V., Gebski, V., Fitzharris, B., Buck, M., Stuart-Harris, R., Beale, P., Goldrick, A. and Rischin, D. (2007). Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01 Gynecol Oncol, 104: p. 647-53. [PMID: 17079006]

95. Wong, A.S. and Leung, P.C. (2007). Role of endocrine and growth factors on the ovarian surface epithelium J Obstet Gynaecol Res, 33: p. 3-16. [PMID: 17212660]

96. Yang, T., Wall, E.M., Milne, K., Theiss, P., Watson, P. and Nelson, B.H. (2007). CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism Clin Cancer Res, 13: p. 7172-80. [PMID: 18056198]

97. Ahmed, N., Maines-Bandiera, S., Quinn, M.A., Unger, W.G., Dedhar, S. and Auersperg, N. (2006). Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium Am J Physiol Cell Physiol, 290: p. C1532-42. [PMID: 16394028]

98. Brewer, M., Kirkpatrick, N.D., Wharton, J.T., Wang, J., Hatch, K., Auersperg, N., Utzinger, U., Gershenson, D., Bast, R. and Zou, C. (2006). 4-HPR modulates gene expression in ovarian cells Int J Cancer, 119: p. 1005-13. [PMID: 16570282]

99. Brown, L.A., Irving, J., Parker, R., Kim, H., Press, J.Z., Longacre, T.A., Chia, S., Magliocco, A., Makretsov, N., Gilks, B., Pollack, J. and Huntsman, D. (2006). Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas Gynecol Oncol, 100: p. 264-70. [PMID: 16236351]

100. Cheung, L.W., Au, S.C., Cheung, A.N., Ngan, H.Y., Tombran-Tink, J., Auersperg, N. and Wong, A.S. (2006). Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells Endocrinology, 147: p. 4179-91. [PMID: 16777976]

101. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells Endocr Relat Cancer, 13: p. 641-51. [PMID: 16728589]

102. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells Cancer Res, 66: p. 3912-20. [PMID: 16585220]

103. Choi, J.H., Gilks, C.B., Auersperg, N. and Leung, P.C. (2006). Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary J Clin Endocrinol Metab, 91: p. 4562-70. [PMID: 16954155]

104. de Lemos, M.L., Hamata, L., Conklin, J. and Swenerton, K. (2006). Potential underdosing of carboplatin in gynecological malignancies Gynecol Oncol, 102: p. 599. [PMID: 16815537]

105. de Lemos, M.L., Hsieh, T., Hamata, L., Levin, A., Swenerton, K., Djurdjev, O., Vu, T., Hu, F., Conklin, J. and Malfair Taylor, S.C. (2006). Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies Gynecol Oncol, 103: p. 1063-9. [PMID: 16875719]

106. Erkanli, A., Taylor, D.D., Dean, D., Eksir, F., Egger, D., Geyer, J., Nelson, B.H., Stone, B., Fritsche, H.A. and Roden, R.B. (2006). Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection Cancer Res, 66: p. 1792-8. [PMID: 16452240]

107. Kim, K.Y., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway Endocr Relat Cancer, 13: p. 211-20. [PMID: 16601289]

108. Mao, T.L., Hsu, C.Y., Yen, M.J., Gilks, B., Sheu, J.J., Gabrielson, E., Vang, R., Cope, L., Kurman, R.J., Wang, T.L. and Shih Ie, M. (2006). Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma Hum Pathol, 37: p. 1169-75. [PMID: 16938522]

109. Ota, T., Choi, K.B., Gilks, C.B., Leung, P.C. and Auersperg, N. (2006). Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9 Differentiation, 74: p. 1-10. [PMID: 16466395]

110. Plante, M., Lau, S., Brydon, L., Swenerton, K., LeBlanc, R. and Roy, M. (2006). Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report Gynecol Oncol, 101: p. 367-70. [PMID: 16542714]

111. Xu, G., Zhou, H., Wang, Q., Auersperg, N. and Peng, C. (2006). Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines Mol Cancer Res, 4: p. 235-46. [PMID: 16603637]

112. Auersperg, N. (2005). Re: "Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma" Gynecol Oncol, 97: p. 302-4; author reply 304-5. [PMID: 15790484]

113. Brewer, M., Wharton, J.T., Wang, J., McWatters, A., Auersperg, N., Gershenson, D., Bast, R. and Zou, C. (2005). In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer Gynecol Oncol, 98: p. 182-92. [PMID: 15907982]

114. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2005). Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr Relat Cancer, 12: p. 407-21. [PMID: 15947112]

115. Dark, G.G., Calvert, A.H., Grimshaw, R., Poole, C., Swenerton, K., Kaye, S., Coleman, R., Jayson, G., Le, T., Ellard, S., Trudeau, M., Vasey, P., Hamilton, M., Cameron, T., Barrett, E., Walsh, W., McIntosh, L. and Eisenhauer, E.A. (2005). Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group J Clin Oncol, 23: p. 1859-66. [PMID: 15699482]

116. Ehlen, T.G., Hoskins, P.J., Miller, D., Whiteside, T.L., Nicodemus, C.F., Schultes, B.C. and Swenerton, K.D. (2005). A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer Int J Gynecol Cancer, 15: p. 1023-34. [PMID: 16343178]

117. Elishaev, E., Gilks, C.B., Miller, D., Srodon, M., Kurman, R.J. and Ronnett, B.M. (2005). Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms Am J Surg Pathol, 29: p. 281-94. [PMID: 15725796]

118. Feng, Q., Li, P., Salamanca, C., Huntsman, D., Leung, P.C. and Auersperg, N. (2005). Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis Cancer Res, 65: p. 8591-6. [PMID: 16204022]

119. Gilks, C.B., Vanderhyden, B.C., Zhu, S., van de Rijn, M. and Longacre, T.A. (2005). Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling Gynecol Oncol, 96: p. 684-94. [PMID: 15721412]

120. He, Q.Y., Zhou, Y., Wong, E., Ehlen, T.G., Auersperg, N., Chiu, J.F. and Wong, A.S. (2005). Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies Gynecol Oncol, 98: p. 68-76. [PMID: 15913737]

121. Kim, K.Y., Choi, K.C., Park, S.H., Auersperg, N. and Leung, P.C. (2005). Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation J Clin Endocrinol Metab, 90: p. 1670-7. [PMID: 15598681]

122. Le, L.H., Swenerton, K.D., Elit, L., Provencher, D.M., Stuart, G.C., Le, T., Lee, U., Rodgers, A., Pond, G.R., Hu, H. and Oza, A.M. (2005). Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies Int J Gynecol Cancer, 15: p. 799-806. [PMID: 16174227]

123. Lee, C.H., Huntsman, D.G., Cheang, M.C., Parker, R.L., Brown, L., Hoskins, P., Miller, D. and Gilks, C.B. (2005). Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma Int J Gynecol Pathol, 24: p. 147-52. [PMID: 15782071]

124. Lee, C.H., Xue, H., Sutcliffe, M., Gout, P.W., Huntsman, D.G., Miller, D.M., Gilks, C.B. and Wang, Y.Z. (2005). Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models Gynecol Oncol, 96: p. 48-55. [PMID: 15589579]

125. Ludwick, C., Gilks, C.B., Miller, D., Yaziji, H. and Clement, P.B. (2005). Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature Int J Gynecol Pathol, 24: p. 205-17. [PMID: 15968194]

126. Pon, Y.L., Auersperg, N. and Wong, A.S. (2005). Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway J Biol Chem, 280: p. 15438-48. [PMID: 15701645]

127. Smith-Beckerman, D.M., Fung, K.W., Williams, K.E., Auersperg, N., Godwin, A.K. and Burlingame, A.L. (2005). Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer Mol Cell Proteomics, 4: p. 156-68. [PMID: 15591324]

128. Symowicz, J., Adley, B.P., Woo, M.M., Auersperg, N., Hudson, L.G. and Stack, M.S. (2005). Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells Cancer Res, 65: p. 2234-42. [PMID: 15781636]

129. Tai, C.J., Chang, S.J., Chien, L.Y., Leung, P.C. and Tzeng, C.R. (2005). Adenosine triphosphate induces activation of caspase-3 in apoptosis of human granulosa-luteal cells Endocr J, 52: p. 327-35. [PMID: 16006727]

130. Tinker, A.V., Bhagat, K., Swenerton, K.D. and Hoskins, P.J. (2005). Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience Gynecol Oncol, 98: p. 54-8. [PMID: 15904950]